Veristat Expands Its Clinical Operations into Europe
April 27, 2016
Veristat announced today that it has been recognized as one of the top 50 fastest-growing private companies in Massachusetts, taking the #35 slot. According to Privco[i], there are over 4,000 private firms operating in Massachusetts today.
Don’t miss Paula Wun’s panel discussion on “Editing Considerations for Submission Documents” at the 5th Annual Regulatory Writing for Product Apporvals Conference.
Join Veristat and industry leaders in regulatory writing and submissions management at the upcoming 5th Annual Regulatory Writing for Product Approvals Conference to share and discuss the challenges of writing regulatory submissions in a continually changing regulatory environment.
Written by Susan Yadlon, BS. Edited by Robin Brodrick.
What Role does Quality Assurance Play at a CRO?
A contract research organization (CRO) has the unique ability to expose QA Specialists to a broad range of therapeutic areas. QA professionals in a CRO must be flexible to a continually changing environment because the role is exciting, never boring, and very fast paced.
March 29, 2016
Join Veristat and other Massachusetts life sciences companies at the MassBio Annual meeting, as they discuss the most critical challenges in bringing new products to market.
March 16, 2016
Video Interviews - Because, What Could Go Wrong?
There is only one thing you need to do to beat your competition in a video interview: Be distraction free.
March 8, 2016
Veristat Strengthens Senior Management Team
Appoints Faith Haines Kolb as Vice President, Biometrics
Veristat Participates in Cycle for Survival 2016 and Raises over $20,000 to Fund Rare Cancer Research
March 4, 2016
Veristat Raises $20,355 to Support Rare Cancer Research
On Saturday, February 27th, Team Veristat JOINED THE BATTLE with Cycle for Survival 2016! Team Veristat had riders at both the Boston, MA and Palo Alto, CA events.
February 23, 2016
Support and Honor Rare Disease Day 2016 with Veristat
Rare Disease Day calls attention to the public health issues associated with rare diseases, which affect nearly 30 million Americans and countless others around the world.